Inflammation and Immunity in Cancer edited by Tsukasa Seya, Misako Matsumoto, Keiko Udaka, Noriyuki Sato.

This book overviews cancer immunity from broad scientific fields, based on the concept that cancer is a sort of by-product of infection, inflammation, and host immune response. The innate and acquired arms of the immune system mainly participate in tumor immune surveillance, and their activation is...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Seya, Tsukasa (Editor), Matsumoto, Misako (Editor), Udaka, Keiko (Editor), Sato, Noriyuki (Editor)
Format: eBook
Language:English
Published: Tokyo : Springer Japan : Imprint: Springer, 2015.
Edition:1st ed. 2015.
Series:Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Preface
  • 1 Role of bone marrow-derived CCR1+ cells in colon cancer invasion and metastasis.- 2 PGE2-associated inflammation and gastrointestinal tumorigenesis
  • 3 Regulation of tumor-associated myeloid cells by innate immune signaling
  • 4 The role of PIKfyve in TLR-mediated inflammation and immune responses
  • 5 Emerging roles of an innate immune regulator TAPE in the Toll-like receptor and RIG-I-like receptor pathways
  • 6 Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T-cell leukemia/lymphoma cells
  • 7 Tumor-associated molecular patterns: its implication in tumoricidal inflammation
  • 8 Host factors involved in the propagation and pathogenesis of hepatitis C virus.- 9 HCV-induced inflammation: The role of cross-talk between HCV-infected hepatocytes and stellate cells
  • 10 Development of immunotherapy for hepatocellular carcinoma
  • 11 Development of glypican-3-targeted cancer immunotherapy
  • 12 The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation
  • 13 In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy
  • 14 Enhancement of efficacy of WT1 peptide cancer vaccine by co-administration with immunopotentiating agents: Lessons from mouse models
  • 15 Regulation of antigen-presentation by dendritic cells and its application to cancer immunotherapy
  • 16 A new mode of CTL induction secondary to alteration of pMHCI repertoire by antigen processing defects
  • 17 Progress in clinical use of CCR4 antibody for regulatory T cell suppression
  • 18 Adjuvant Immunotherapy for cancer: Basic research to clinical bench
  • 19 Immunological regulation of human cancer stem cell/cancer-initiating cells (CSC/CIC)
  • 20 Overview on tumor immunology.-BM Epilogue.